AbiVax’s Partnering Prospects For MicroRNA-based Drug Boosted By Rheumatoid Arthritis Data

Phase IIa RA Results Build On Ulcerative Colitis Promise

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.